Skip to content

Effect of Apical Patency and Local Corticosteroid on Pain and Neuropeptides Release in Patients With Symptomatic Irreversible Pulpitis: A Randomized Clinical Trial

Effect of Apical Patency and Local Corticosteroid on Pain and Neuropeptides Release in Patients With Symptomatic Irreversible Pulpitis: A Randomized Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06457828
Enrollment
40
Registered
2024-06-13
Start date
2021-02-01
Completion date
2024-09-30
Last updated
2024-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain, Symptomatic Irreversible Pulpitis

Keywords

Pulpitis, Postoperative Pain, VAS

Brief summary

The goal of this randomized clinical trial is to learn the effect of using local corticosteroids and maintaining apical patency in reducing post-preparation pain in patients with acute irreversible pulpitis in molar teeth. The main question it aims to answer is: • How effective are using local corticosteroids and maintaining apical patency in reducing post-preparation pain in patients with acute irreversible pulpitis? Participants will be asked to fill a visual analogue scale to record their pain, after receiving a root canal treatment while using local corticosteroids or not as well as maintaining apical patency or not. Researchers will compare the use of corticosteroids and maintaining apical patency in reducing post-operative pain.

Interventions

PROCEDURENon-corticosteroid injection

no infiltration injection of 0.7 ml of dexamethasone lateral to the involved tooth after anesthesia administration.

DRUGCorticosteroid injection

infiltration injection of 0.7 ml of dexamethasone lateral to the involved tooth after anesthesia administration.

Sponsors

Suez Canal University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Symptomatic acute irreversible pulpitis in molar teeth. * Normal periapical condition including periapical radiography with minimal widening of periodontal ligament. * Normal probing depth. * No medical condition. * No contraindication for administration of corticosteroids and local anesthesia.

Exclusion criteria

* Facial or oral paresthesia. * Pregnancy & breastfeeding. * Unrestorable tooth. * Marginal periodontal disease. * Presence of a crown on the tooth involved. * Over instrumentation during root canal treatment. * Long-term use of corticosteroids. * False-positive cases of sensibility test with necrosis discovered after gaining access to the tooth. * Cases requiring intrapulpal injection to promote anesthesia.

Design outcomes

Primary

MeasureTime frameDescription
Post-operative pain6, 12, 24, 48, 72 hour and 7 days postoperative intervalsPatients were instructed to record their pain level using the Visual Analog Scale
Inflammatory markersbefore treatment, after 3 days and after 7 daysGingival crevicular fluid samples were collected by periopaper for testing the level of IL-1β and IL-10

Countries

Egypt

Contacts

Primary ContactMustafa Sultan
sultan_mustafa@hotmail.com+201111506890

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026